FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3169762498> ?p ?o ?g. }

• W3169762498 endingPage "1144" @default.
• W3169762498 startingPage "1135" @default.
• W3169762498 abstract "Introduction: Patients with cancer are at risk of thrombotic events, mainly deep vein thrombosis and/or pulmonary embolism. The thrombosis risk is generally 4-6 times higher than in a healthy population and depends on factors related to patient characteristics, tumor factors, and treatment-related factors. The decision-making for prophylactic anticoagulation is individualized according to the relative risks and benefits. The VTE risk has been quantified using different assessment scores.Areas covered: This article reviews current data and ongoing research on predictive factors involved in cancer-related thrombosis and highlights the currently suggested strategies for prophylaxis. Several trials that compared the two treatment options, direct factor Xa inhibitor or LMWH, with placebo and not each other are discussed. This article analyzed the safety and efficacy features that led several international organizations such as ASCO, NCCN, and others, to issue guidelines for the prophylaxis and treatment of patients at high risk of thrombosis by using LMWH, fondaparinux, and DOACs.Expert opinion: ASCO, NCCN, and other international organizations recommend thromboprophylaxis in high-risk patients. However, further investigation is needed to define better biomarkers for more accurate identification of cancer patients that will benefit from anticoagulant treatment." @default.
• W3169762498 created "2021-06-22" @default.
• W3169762498 creator A5014087122 @default.
• W3169762498 creator A5019478616 @default.
• W3169762498 creator A5019775560 @default.
• W3169762498 creator A5060239604 @default.
• W3169762498 creator A5080387249 @default.
• W3169762498 creator A5084504807 @default.
• W3169762498 date "2021-06-21" @default.
• W3169762498 modified "2023-10-13" @default.
• W3169762498 title "New prophylaxis strategies to reduce the risk of thromboembolism in cancer" @default.
• W3169762498 cites W164440564 @default.
• W3169762498 cites W1821404797 @default.
• W3169762498 cites W1948889300 @default.
• W3169762498 cites W1990670070 @default.
• W3169762498 cites W1995391277 @default.
• W3169762498 cites W1995828607 @default.
• W3169762498 cites W2007086823 @default.
• W3169762498 cites W2017316291 @default.
• W3169762498 cites W2024789639 @default.
• W3169762498 cites W2035056966 @default.
• W3169762498 cites W2039928197 @default.
• W3169762498 cites W2041113507 @default.
• W3169762498 cites W2041585489 @default.
• W3169762498 cites W2050555037 @default.
• W3169762498 cites W2054596351 @default.
• W3169762498 cites W2056208055 @default.
• W3169762498 cites W2072052583 @default.
• W3169762498 cites W2078558642 @default.
• W3169762498 cites W2078840523 @default.
• W3169762498 cites W2080116671 @default.
• W3169762498 cites W2087166268 @default.
• W3169762498 cites W2101185555 @default.
• W3169762498 cites W2111247260 @default.
• W3169762498 cites W2113160384 @default.
• W3169762498 cites W2118615533 @default.
• W3169762498 cites W2126257749 @default.
• W3169762498 cites W2134683286 @default.
• W3169762498 cites W2149588262 @default.
• W3169762498 cites W2158828810 @default.
• W3169762498 cites W2158951260 @default.
• W3169762498 cites W2159407715 @default.
• W3169762498 cites W2166383168 @default.
• W3169762498 cites W2167494200 @default.
• W3169762498 cites W2171851177 @default.
• W3169762498 cites W2290979025 @default.
• W3169762498 cites W2397349375 @default.
• W3169762498 cites W2490019007 @default.
• W3169762498 cites W2535083184 @default.
• W3169762498 cites W2551096297 @default.
• W3169762498 cites W2618070394 @default.
• W3169762498 cites W2619705272 @default.
• W3169762498 cites W2748990043 @default.
• W3169762498 cites W2792857103 @default.
• W3169762498 cites W2807617068 @default.
• W3169762498 cites W2896291420 @default.
• W3169762498 cites W2902078827 @default.
• W3169762498 cites W2912331015 @default.
• W3169762498 cites W2917037555 @default.
• W3169762498 cites W2917722773 @default.
• W3169762498 cites W2972338824 @default.
• W3169762498 cites W3014200667 @default.
• W3169762498 cites W3017326650 @default.
• W3169762498 cites W3023465669 @default.
• W3169762498 cites W3127460195 @default.
• W3169762498 cites W4206798761 @default.
• W3169762498 cites W4249976229 @default.
• W3169762498 cites W4376595850 @default.
• W3169762498 doi "https://doi.org/10.1080/14737140.2021.1941889" @default.
• W3169762498 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34139938" @default.
• W3169762498 hasPublicationYear "2021" @default.
• W3169762498 type Work @default.
• W3169762498 sameAs 3169762498 @default.
• W3169762498 citedByCount "2" @default.
• W3169762498 countsByYear W31697624982022 @default.
• W3169762498 crossrefType "journal-article" @default.
• W3169762498 hasAuthorship W3169762498A5014087122 @default.
• W3169762498 hasAuthorship W3169762498A5019478616 @default.
• W3169762498 hasAuthorship W3169762498A5019775560 @default.
• W3169762498 hasAuthorship W3169762498A5060239604 @default.
• W3169762498 hasAuthorship W3169762498A5080387249 @default.
• W3169762498 hasAuthorship W3169762498A5084504807 @default.
• W3169762498 hasConcept C121608353 @default.
• W3169762498 hasConcept C12174686 @default.
• W3169762498 hasConcept C126322002 @default.
• W3169762498 hasConcept C177713679 @default.
• W3169762498 hasConcept C2776265017 @default.
• W3169762498 hasConcept C2776877702 @default.
• W3169762498 hasConcept C2776884760 @default.
• W3169762498 hasConcept C2778205648 @default.
• W3169762498 hasConcept C2778959117 @default.
• W3169762498 hasConcept C2780868729 @default.
• W3169762498 hasConcept C2908647359 @default.
• W3169762498 hasConcept C2991741193 @default.
• W3169762498 hasConcept C38652104 @default.
• W3169762498 hasConcept C41008148 @default.
• W3169762498 hasConcept C535046627 @default.
• W3169762498 hasConcept C71924100 @default.

• next